With most of the world being in lockdown we are all looking for new ways to continue to lead our lives as normally as possible, from personal Zoom quiz nights with family to gathering marke
Almost exactly six years ago AstraZeneca managed to convince investors to reject a takeover bid from Pfizer – and now the UK pharma is reportedly planning its own mega-merger with Gilead. <
COVID-19 has left no part of life untouched, including health technology assessment (HTA) and other payer agency activities, and it will likely have a lasting impact on market access.
AstraZeneca has announced new plans to increase the global supply of Oxford University’s COVID-19 vaccine to more than two billion doses after striking agreements with several global not-fo
Almost 10 million patients could be on waiting lists for NHS treatment by the end of the year amid the anticipated second peak of the COVID-19 outbreak, according to estimates from the make